Schilke Tobin Insider Trades

Insider Trading History

Track insider trading activity for Schilke Tobin. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Crinetics Pharmaceuticals
Crinetics Pharmaceuticals CRNX
Chief Financial Officer
Holding Value $2.59M 78,121 shares
Last Trade
Mar 03, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$266k 6,713 shares
$39.67
$33.09
Crinetics Pharmaceuticals
Crinetics Pharmaceuticals CRNX
Chief Financial Officer
Holding Value $2.81M 84,834 shares
Last Trade
Feb 23, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.59M 82,000 shares
$43.79
$33.09
Crinetics Pharmaceuticals
Crinetics Pharmaceuticals CRNX
Chief Financial Officer
Holding Value $2.65M 80,000 shares
Last Trade
Mar 10, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.7M 80,000 shares
$33.75
$33.09
Revance Therapeutics
Revance Therapeutics RVNC
CFO
Holding Value $0 0 shares
Last Trade
Feb 06, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$76.2k 20,883 shares
$3.65
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
CFO
Holding Value $76.2k 20,883 shares
Last Trade
Feb 06, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$76.2k 20,883 shares
$3.65
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
CFO
Holding Value $378k 103,555 shares
Last Trade
Feb 04, 2025 Sale (Tender)Reported as Tender on SEC Form 4.
$358k 97,999 shares
$3.65
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
CFO
Holding Value $736k 201,554 shares
Last Trade
Feb 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$25.1k 6,888 shares
$3.64
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
CFO
Holding Value $711k 194,666 shares
Last Trade
Dec 31, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.04k 1,000 shares
$3.04
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
CFO
Holding Value $707k 193,666 shares
Last Trade
Jun 30, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.57k 1,000 shares
$2.57
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
CFO
Holding Value $703k 192,666 shares
Last Trade
Mar 18, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$47.2k 9,361 shares
$5.04
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
CFO
Holding Value $737k 202,027 shares
Last Trade
Mar 15, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$20.3k 3,822 shares
$5.31
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
CFO
Holding Value $751k 205,849 shares
Last Trade
Feb 29, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$125k 17,447 shares
$7.14
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
CFO
Holding Value $335k 91,735 shares
Last Trade
Dec 31, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.81k 434 shares
$8.79
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
CFO
Holding Value $333k 91,301 shares
Last Trade
Aug 11, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$212k 11,215 shares
$18.91
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
CFO
Holding Value $374k 102,516 shares
Last Trade
Aug 11, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$428k 22,620 shares
$18.91
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
CFO
Holding Value $292k 79,896 shares
Last Trade
Jul 03, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$42.6k 1,701 shares
$25.04
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
CFO
Holding Value $298k 81,597 shares
Last Trade
Jun 30, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$19.5k 769 shares
$25.31
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
CFO
Holding Value $295k 80,828 shares
Last Trade
Jun 02, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$15.5k 500 shares
$31.00
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
CFO
Holding Value $297k 81,328 shares
Last Trade
Jun 01, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$82.6k 2,701 shares
$30.57
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
CFO
Holding Value $307k 84,029 shares
Last Trade
May 15, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$739k 21,401 shares
$34.55
$3.65

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up